EE112 Budget Impact Analysis of Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low, Intermediate, and High-Risk Patients with Severe, Symptomatic Aortic Stenosis in the United States

P.Y." Cheng,J Yu,A Figucia,J Carapinha

doi:10.1016/j.jval.2023.03.416

EE112 Budget Impact Analysis of Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low, Intermediate, and High-Risk Patients with Severe, Symptomatic Aortic Stenosis in the United States

P.Y." Cheng, J Yu + Show 2 more

https://doi.org/10.1016/j.jval.2023.03.416

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Publication Date: Jun 1, 2023

Affiliation: Northeastern University

#Versus Surgical Aortic Valve Replacement #Surgical Aortic Valve Replacement + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

A budget impact analysis (BIA) comparing transcatheter aortic valve replacement (TAVR) with SAPIEN 3 versus surgical aortic valve replacement (SAVR) for severe, symptomatic aortic stenosis (SSAS) among patients of low, intermediate, and high surgical risk.

Full Text